In the central nervous system, NADPH oxidases are thought to contribute to pathophysiologies including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, anxiety, epilepsy, and schizophrenia [77,78]. The gene discussed is FMO5; the disease is early-onset autosomal dominant Alzheimer disease.